DOC
Healthpeak Properties, Inc.
Price Chart
Latest Quote
$19.56
+0.16 (+0.82%)
Current Price
| Previous Close | $19.40 |
| Open | $19.67 |
| Day High | $19.73 |
| Day Low | $19.43 |
| Volume | 5,002,726 |
Stock Information
| Quarterly Dividend / Yield | $1.22 / 6.24% |
| Shares Outstanding | 689.42M |
| Quarterly Dividend Yield | 6.24% |
| Quarterly Dividend | $1.22 |
| Total Debt | $10.71B |
| Cash Equivalents | $1.18B |
| Revenue | $2.87B |
| Net Income | $221.63M |
| Sector | Real Estate |
| Industry | REIT - Healthcare Facilities |
| Market Cap | $13.49B |
| P/E Ratio | 61.12 |
| EPS (TTM) | $0.32 |
| Exchange | NYQ |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $24.25B |
| Sales | $2.87B |
| Income | $221.63M |
| Book/sh | $11.26 |
| Cash/sh | $1.71 |
| Employees | 411 |
Financial Ratios
| Quick Ratio | 1.41 |
| Current Ratio | 2.04 |
| Debt/Eq | 118.24 |
| EPS Growth TTM | 352.10% |
Returns & Margins
| ROA | 1.50% |
| ROE | 2.80% |
| Gross Margin | 58.33% |
| Operating Margin | 12.31% |
| Profit Margin | 7.73% |
Ownership
| Insider Ownership | 0.30% |
| Institutional Ownership | 102.67% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| Forward P/E | 130.40 |
| PEG | 4.32 |
| P/S | 4.69 |
| P/B | 1.74 |
Analyst Data
| Recommendation | buy |
| Target Price | $21.28 |
Technical Indicators
| SMA20 | $19.73 |
| SMA50 | $18.38 |
| SMA200 | $17.24 |
| RSI | 56.25 |
| ATR | 0.5104 |
| Shares Float | 686.66M |
| Short Float | 5.24% |
| Short Ratio | 2.51 |
| Volatility | 1.03 |
| Rel Volume | 1.19 |
Performance History
| Week | -4.11% |
| Month | +1.85% |
| Quarter | +12.12% |
| 6 Months | +24.49% |
| YTD | +24.94% |
| Year | +23.18% |
| 3 Years | +14.15% |
| 5 Years | -25.72% |
| 10 Years | +4.78% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-18 | $19.56 | 11,513,600 |
| 2026-06-17 | $19.40 | 5,223,000 |
| 2026-06-16 | $20.09 | 6,879,300 |
| 2026-06-15 | $20.43 | 9,183,200 |
| 2026-06-12 | $20.59 | 5,278,000 |
| 2026-06-11 | $20.40 | 6,970,300 |
| 2026-06-10 | $20.37 | 4,995,000 |
| 2026-06-09 | $20.40 | 8,129,600 |
| 2026-06-08 | $19.67 | 7,656,000 |
| 2026-06-05 | $19.69 | 5,488,500 |
| 2026-06-04 | $19.50 | 7,032,100 |
| 2026-06-03 | $18.98 | 6,120,500 |
| 2026-06-02 | $19.35 | 8,968,500 |
| 2026-06-01 | $18.91 | 6,470,700 |
| 2026-05-29 | $19.06 | 61,925,800 |
| 2026-05-28 | $19.41 | 9,227,600 |
| 2026-05-27 | $19.77 | 7,096,200 |
| 2026-05-26 | $19.93 | 6,425,100 |
| 2026-05-22 | $19.63 | 5,630,500 |
| 2026-05-21 | $19.54 | 3,994,400 |
| 2026-05-20 | $19.56 | 5,814,400 |
| 2026-05-19 | $19.20 | 3,862,600 |
| 2026-05-18 | $nan | 0 |
About Healthpeak Properties, Inc.
Healthpeak Properties, Inc. is a Standard & Poor's 500 company that owns, operates, and develops high-quality real estate focused on healthcare discovery and delivery in the United States. Our company was originally founded in 1985. We are organized as an umbrella partnership REIT. We hold substantially all our assets and conduct our operations through our operating subsidiary, Healthpeak OP, a consolidated subsidiary of which we are the managing member. We are a Maryland corporation and qualify as a self-administered REIT. We are headquartered in Denver, Colorado, with additional corporate offices in California, Tennessee, Wisconsin, and Massachusetts and property management offices in several locations throughout the U.S. We have a diversified portfolio of high-quality healthcare properties across three core asset classes of outpatient medical, lab, and continuing care retirement community real estate. Under the outpatient medical and lab segments, we own, operate, and develop outpatient medical buildings, hospitals, and lab buildings. Under the CCRC segment, our properties are operated through RIDEA structures. We have other non-reportable segments that are comprised primarily of: (i) an interest in an unconsolidated joint venture that owns 19 senior housing assets, (ii) loans receivable, and (iii) a preferred equity investment. These non-reportable segments have been presented on a combined basis herein. At September 30, 2025, our portfolio of investments, including properties in certain of our unconsolidated joint ventures, consisted of interests in 703 properties: (i) Outpatient medical  530 properties; (ii) Lab  139 properties; (iii) CCRC  15 properties; and (iv) Other non-reportable  19 properties. Healthpeak Properties, Inc. was incorporated in 1985 in Maryland, USA.
đ° Latest News
BMO Capital and Morgan Stanley Take Different Views on Healthpeak Properties (DOC)
Insider Monkey âĸ 2026-06-17T19:11:07Z
Jim Cramer Highlights Healthpeak Properties and Its Strong Dividend Yield
Insider Monkey âĸ 2026-06-15T08:04:56Z
SpaceX initiated, Intel upgraded: Wall Street's top analyst calls
The Fly âĸ 2026-06-11T13:38:31Z
Diversified Healthcare (DHC) Surges 5.9%: Is This an Indication of Further Gains?
Zacks âĸ 2026-06-10T11:49:00Z
How Investors Are Reacting To Healthpeak Properties (DOC) Raised 2026 FFOA Outlook And Janus Living IPO Proceeds
Simply Wall St. âĸ 2026-06-08T01:07:52Z
Is It Time To Reassess Healthpeak Properties (DOC) After Its Strong Year To Date Rally
Simply Wall St. âĸ 2026-06-07T12:06:28Z
Healthpeak (DOC) Down 2.2% Since Last Earnings Report: Can It Rebound?
Zacks âĸ 2026-06-04T15:30:12Z
8 Dividend S&P 500 Stocks Yield Enough To Still Be Worthwhile
Investor's Business Daily âĸ 2026-05-28T12:00:54Z
Healthpeak Properties Gains 22.7% Year to Date: Will the Trend Last?
Zacks âĸ 2026-05-26T17:37:00Z
SPHDâs High Dividend Low Volatility Promise Has Returned Just 6 Percent Annualized While the S&P 500 Doubled It
24/7 Wall St. âĸ 2026-05-26T15:30:20Z
Period:
Loading...
Income Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Reconciled Cost Of Revenue | $1,165,846,000 | $1,105,616,000 | $927,851,000 | $862,991,000 |
| Cost Of Revenue | $1,129,099,000 | $1,074,861,000 | $902,060,000 | $862,991,000 |
| Total Revenue | $2,822,512,000 | $2,700,449,000 | $2,181,003,000 | $2,061,178,000 |
| Operating Revenue | $2,822,512,000 | $2,700,449,000 | $2,181,003,000 | $2,061,178,000 |
| Expenses | ||||
| Interest Expense | $305,178,000 | $280,430,000 | $200,331,000 | $172,944,000 |
| Total Expenses | $2,278,380,000 | $2,229,228,000 | $1,747,093,000 | $1,704,593,000 |
| Other Income Expense | $45,340,000 | $82,377,000 | $81,357,000 | $323,489,000 |
| Other Non Operating Income Expenses | $479,000 | $59,345,000 | $6,808,000 | $326,268,000 |
| Net Non Operating Interest Income Expense | $-305,178,000 | $-280,430,000 | $-200,331,000 | $-172,944,000 |
| Interest Expense Non Operating | $305,178,000 | $280,430,000 | $200,331,000 | $172,944,000 |
| Operating Expense | $1,149,281,000 | $1,154,367,000 | $845,033,000 | $841,602,000 |
| General And Administrative Expense | $90,416,000 | $97,162,000 | $95,132,000 | $131,033,000 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $71,347,000 | $243,142,000 | $306,009,000 | $497,565,000 |
| Net Interest Income | $-305,178,000 | $-280,430,000 | $-200,331,000 | $-172,944,000 |
| Normalized Income | $27,950,838 | $220,476,768 | $247,115,290 | $499,760,410 |
| Net Income From Continuing And Discontinued Operation | $71,347,000 | $243,142,000 | $306,009,000 | $500,449,000 |
| Average Dilution Earnings | $0 | $107,000 | $0 | - |
| Net Income Common Stockholders | $70,513,000 | $242,384,000 | $304,284,000 | $497,792,000 |
| Net Income | $71,347,000 | $243,142,000 | $306,009,000 | $500,449,000 |
| Net Income Including Noncontrolling Interests | $101,027,000 | $267,303,000 | $334,757,000 | $516,424,000 |
| Net Income Continuous Operations | $101,027,000 | $267,303,000 | $334,757,000 | $513,540,000 |
| Earnings From Equity Interest Net Of Tax | $-173,984,000 | $-1,515,000 | $10,204,000 | $1,985,000 |
| Pretax Income | $284,294,000 | $273,168,000 | $314,936,000 | $507,130,000 |
| Special Income Charges | $-24,627,000 | $-155,663,000 | $-11,914,000 | $-11,857,000 |
| Operating Income | $544,132,000 | $471,221,000 | $433,910,000 | $356,585,000 |
| Depreciation Amortization Depletion Income Statement | $1,058,865,000 | $1,057,205,000 | $749,901,000 | $710,569,000 |
| Depreciation And Amortization In Income Statement | $1,058,865,000 | $1,057,205,000 | $749,901,000 | $710,569,000 |
| Gross Profit | $1,693,413,000 | $1,625,588,000 | $1,278,943,000 | $1,198,187,000 |
| Net Income Discontinuous Operations | - | $0 | $0 | $2,884,000 |
| Per Share | ||||
| Diluted EPS | $0.10 | $0.36 | $0.56 | $0.92 |
| Basic EPS | $0.10 | $0.36 | $0.56 | $0.92 |
| Other | ||||
| Tax Effect Of Unusual Items | $1,464,838 | $366,768 | $15,655,290 | $-583,590 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $1,603,476,000 | $1,587,771,000 | $1,190,619,000 | $1,393,422,000 |
| Total Unusual Items | $44,861,000 | $23,032,000 | $74,549,000 | $-2,779,000 |
| Total Unusual Items Excluding Goodwill | $44,861,000 | $23,032,000 | $74,549,000 | $-2,779,000 |
| Reconciled Depreciation | $1,022,118,000 | $1,026,450,000 | $724,110,000 | $710,569,000 |
| EBITDA (Bullshit earnings) | $1,648,337,000 | $1,610,803,000 | $1,265,168,000 | $1,390,643,000 |
| EBIT | $589,472,000 | $553,598,000 | $515,267,000 | $680,074,000 |
| Diluted Average Shares | $696,044,000 | $676,233,000 | $547,275,000 | $539,147,000 |
| Basic Average Shares | $696,026,000 | $675,680,000 | $547,006,000 | $538,809,000 |
| Diluted NI Availto Com Stockholders | $70,513,000 | $242,491,000 | $304,284,000 | $497,792,000 |
| Otherunder Preferred Stock Dividend | $834,000 | $758,000 | $1,725,000 | $2,657,000 |
| Minority Interests | $-29,680,000 | $-24,161,000 | $-28,748,000 | $-15,975,000 |
| Tax Provision | $9,283,000 | $4,350,000 | $-9,617,000 | $-4,425,000 |
| Write Off | $-893,000 | $22,978,000 | $-5,601,000 | $7,004,000 |
| Restructuring And Mergern Acquisition | $25,520,000 | $132,685,000 | $17,515,000 | $4,853,000 |
| Gain On Sale Of Security | $69,488,000 | $178,695,000 | $86,463,000 | $9,078,000 |
| Selling General And Administration | $90,416,000 | $97,162,000 | $95,132,000 | $131,033,000 |
| Other Gand A | $90,416,000 | $97,162,000 | $95,132,000 | $131,033,000 |
| Other Special Charges | - | - | - | - |
Fetched: 2026-06-17
Balance Sheet (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $6,777,049,000 | $7,515,493,000 | $6,036,290,000 | $6,236,640,000 |
| Total Assets | $20,336,018,000 | $19,938,255,000 | $15,698,850,000 | $15,771,229,000 |
| Total Non Current Assets | $19,033,348,000 | $19,013,383,000 | $15,137,571,000 | $15,166,261,000 |
| Other Non Current Assets | $885,161,000 | $819,951,000 | $772,044,000 | $780,722,000 |
| Non Current Deferred Assets | $111,248,000 | $115,258,000 | - | - |
| Non Current Deferred Taxes Assets | $111,248,000 | $115,258,000 | - | - |
| Goodwill And Other Intangible Assets | $723,045,000 | $885,783,000 | $314,156,000 | $418,061,000 |
| Other Intangible Assets | $654,516,000 | $817,254,000 | $314,156,000 | $418,061,000 |
| Current Assets | $1,302,670,000 | $924,872,000 | $561,279,000 | $604,968,000 |
| Assets Held For Sale Current | $80,621,000 | $7,840,000 | $117,986,000 | $49,866,000 |
| Restricted Cash | $70,245,000 | $64,487,000 | $51,388,000 | $54,802,000 |
| Receivables | $684,347,000 | $732,727,000 | $274,270,000 | $428,268,000 |
| Loans Receivable | $606,020,000 | $655,917,000 | $218,450,000 | $374,832,000 |
| Accounts Receivable | $78,327,000 | $76,810,000 | $55,820,000 | $53,436,000 |
| Allowance For Doubtful Accounts Receivable | $-2,018,000 | $-2,243,000 | $-2,282,000 | $-2,399,000 |
| Gross Accounts Receivable | $80,345,000 | $79,053,000 | $58,102,000 | $55,835,000 |
| Cash Cash Equivalents And Short Term Investments | $467,457,000 | $119,818,000 | $117,635,000 | $72,032,000 |
| Cash And Cash Equivalents | $467,457,000 | $119,818,000 | $117,635,000 | $72,032,000 |
| Debt | ||||
| Net Debt | $9,380,437,000 | $8,596,231,000 | $6,758,664,000 | $6,425,581,000 |
| Total Debt | $10,144,154,000 | $9,023,269,000 | $7,083,042,000 | $6,706,128,000 |
| Long Term Debt And Capital Lease Obligation | $9,065,304,000 | $8,873,269,000 | $6,363,042,000 | $5,710,522,000 |
| Long Term Debt | $8,769,044,000 | $8,566,049,000 | $6,156,299,000 | $5,502,007,000 |
| Current Debt And Capital Lease Obligation | $1,078,850,000 | $150,000,000 | $720,000,000 | $995,606,000 |
| Current Debt | $1,078,850,000 | $150,000,000 | $720,000,000 | $995,606,000 |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $12,033,567,000 | $10,880,631,000 | $8,773,980,000 | $8,482,952,000 |
| Total Non Current Liabilities Net Minority Interest | $10,224,308,000 | $10,005,289,000 | $7,396,055,000 | $6,710,791,000 |
| Other Non Current Liabilities | $173,697,000 | $191,884,000 | $127,380,000 | $156,193,000 |
| Non Current Deferred Liabilities | $985,307,000 | $940,136,000 | $905,633,000 | $844,076,000 |
| Current Liabilities | $1,809,259,000 | $875,342,000 | $1,377,925,000 | $1,772,161,000 |
| Other Current Liabilities | $11,900,000 | - | $729,000 | $4,070,000 |
| Payables And Accrued Expenses | $718,509,000 | $725,342,000 | $657,196,000 | $772,485,000 |
| Interest Payable | $89,202,000 | $76,040,000 | $59,492,000 | $59,291,000 |
| Payables | $263,636,000 | $275,972,000 | $240,258,000 | $265,596,000 |
| Accounts Payable | $263,636,000 | $275,972,000 | $240,258,000 | $265,596,000 |
| Equity | ||||
| Common Stock Equity | $7,500,094,000 | $8,401,276,000 | $6,350,446,000 | $6,654,701,000 |
| Total Equity Gross Minority Interest | $8,302,451,000 | $9,057,624,000 | $6,924,870,000 | $7,288,277,000 |
| Stockholders Equity | $7,500,094,000 | $8,401,276,000 | $6,350,446,000 | $6,654,701,000 |
| Other Equity Interest | $-5,952,920,000 | $-5,174,279,000 | $-4,621,861,000 | $-4,269,689,000 |
| Gains Losses Not Affecting Retained Earnings | $-9,937,000 | $28,818,000 | $19,371,000 | $28,134,000 |
| Other Equity Adjustments | $-9,937,000 | $28,818,000 | $19,371,000 | $28,134,000 |
| Long Term Equity Investment | $802,601,000 | $936,814,000 | $782,853,000 | $706,677,000 |
| Retained Earnings | - | - | - | $-4,269,689,000 |
| Other | ||||
| Ordinary Shares Number | $695,036,731 | $699,485,139 | $547,156,311 | $546,641,973 |
| Share Issued | $695,036,731 | $699,485,139 | $547,156,311 | $546,641,973 |
| Tangible Book Value | $6,777,049,000 | $7,515,493,000 | $6,036,290,000 | $6,236,640,000 |
| Invested Capital | $17,347,988,000 | $17,117,325,000 | $13,226,745,000 | $13,152,314,000 |
| Working Capital | $-506,589,000 | $49,530,000 | $-816,646,000 | $-1,167,193,000 |
| Capital Lease Obligations | $296,260,000 | $307,220,000 | $206,743,000 | $208,515,000 |
| Total Capitalization | $16,269,138,000 | $16,967,325,000 | $12,506,745,000 | $12,156,708,000 |
| Minority Interest | $802,357,000 | $656,348,000 | $574,424,000 | $633,576,000 |
| Additional Paid In Capital | $12,767,914,000 | $12,847,252,000 | $10,405,780,000 | $10,349,614,000 |
| Capital Stock | $695,037,000 | $699,485,000 | $547,156,000 | $546,642,000 |
| Common Stock | $695,037,000 | $699,485,000 | $547,156,000 | $546,642,000 |
| Non Current Deferred Revenue | $985,307,000 | $940,136,000 | $905,633,000 | $844,076,000 |
| Long Term Capital Lease Obligation | $296,260,000 | $307,220,000 | $206,743,000 | $208,515,000 |
| Current Accrued Expenses | $454,873,000 | $449,370,000 | $416,938,000 | $506,889,000 |
| Investments And Advances | $802,601,000 | $936,814,000 | $782,853,000 | $706,677,000 |
| Investmentsin Joint Venturesat Cost | $802,601,000 | $936,814,000 | $782,853,000 | $706,677,000 |
| Investment Properties | $16,099,095,000 | $15,831,404,000 | $13,028,363,000 | $13,023,483,000 |
| Goodwill | $68,529,000 | $68,529,000 | - | - |
| Net PPE | $412,198,000 | $424,173,000 | $240,155,000 | $237,318,000 |
| Gross PPE | $412,198,000 | $424,173,000 | $240,155,000 | $237,318,000 |
| Other Properties | $412,198,000 | $424,173,000 | $240,155,000 | $237,318,000 |
| Commercial Paper | - | $150,000,000 | $720,000,000 | - |
| Treasury Shares Number | - | - | $0 | - |
| Line Of Credit | - | - | $720,000,000 | $995,606,000 |
| Other Investments | - | - | - | $0 |
Fetched: 2026-06-17
Cash Flow Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $1,251,959,000 | $1,070,497,000 | $956,242,000 | $900,261,000 |
| Operating Activities | ||||
| Operating Cash Flow | $1,251,959,000 | $1,070,497,000 | $956,242,000 | $900,261,000 |
| Cash Flow From Continuing Operating Activities | $1,251,959,000 | $1,070,497,000 | $956,242,000 | $900,261,000 |
| Operating Gains Losses | $104,496,000 | $-254,728,000 | $-96,901,000 | $-346,602,000 |
| Investing Activities | ||||
| Investing Cash Flow | $-1,034,673,000 | $-113,799,000 | $-576,754,000 | $-876,343,000 |
| Cash Flow From Continuing Investing Activities | $-1,034,673,000 | $-113,799,000 | $-576,754,000 | $-876,343,000 |
| Net Other Investing Changes | $-63,768,000 | $-65,817,000 | $96,399,000 | $-1,819,000 |
| Financing Activities | ||||
| Repurchase Of Capital Stock | $-97,145,000 | $-190,690,000 | $-6,524,000 | $-67,838,000 |
| Issuance Of Capital Stock | $1,146,000 | $317,000 | $278,000 | $308,100,000 |
| Financing Cash Flow | $136,111,000 | $-941,416,000 | $-337,299,000 | $-116,532,000 |
| Cash Flow From Continuing Financing Activities | $136,111,000 | $-941,416,000 | $-337,299,000 | $-116,532,000 |
| Net Other Financing Charges | $-27,473,000 | $-109,480,000 | $-52,115,000 | $-33,330,000 |
| Cash Dividends Paid | $-849,095,000 | $-794,783,000 | $-657,021,000 | $-648,047,000 |
| Common Stock Dividend Paid | $-849,095,000 | $-794,783,000 | $-657,021,000 | $-648,047,000 |
| Net Common Stock Issuance | $-95,999,000 | $-190,373,000 | $-6,246,000 | $240,262,000 |
| Common Stock Issuance | $1,146,000 | $317,000 | $278,000 | $308,100,000 |
| Dividends Received Cfi | $28,503,000 | $22,906,000 | $20,640,000 | $12,518,000 |
| Dividend Received Cfo | $17,117,000 | $12,000,000 | $910,000 | $943,000 |
| Other | ||||
| Repayment Of Debt | $-11,999,652,000 | $-4,338,030,000 | $-10,710,400,000 | $-16,057,570,000 |
| Issuance Of Debt | $13,108,330,000 | $4,491,250,000 | $11,088,483,000 | $16,382,153,000 |
| Interest Paid Supplemental Data | $260,109,000 | $249,471,000 | $188,213,000 | $162,115,000 |
| Income Tax Paid Supplemental Data | $3,414,000 | $7,862,000 | $1,923,000 | - |
| End Cash Position | $537,702,000 | $184,305,000 | $169,023,000 | $126,834,000 |
| Beginning Cash Position | $184,305,000 | $169,023,000 | $126,834,000 | $219,448,000 |
| Changes In Cash | $353,397,000 | $15,282,000 | $42,189,000 | $-92,614,000 |
| Common Stock Payments | $-97,145,000 | $-190,690,000 | $-6,524,000 | $-67,838,000 |
| Net Issuance Payments Of Debt | $1,108,678,000 | $153,220,000 | $378,083,000 | $324,583,000 |
| Net Long Term Debt Issuance | $1,108,678,000 | $153,220,000 | $378,083,000 | $324,583,000 |
| Long Term Debt Payments | $-11,999,652,000 | $-4,338,030,000 | $-10,710,400,000 | $-16,057,570,000 |
| Long Term Debt Issuance | $13,108,330,000 | $4,491,250,000 | $11,088,483,000 | $16,382,153,000 |
| Net Investment Properties Purchase And Sale | $-912,635,000 | $44,267,000 | $-605,402,000 | $-991,884,000 |
| Sale Of Investment Properties | $337,724,000 | $648,548,000 | $141,651,000 | $47,885,000 |
| Purchase Of Investment Properties | $-1,250,359,000 | $-604,281,000 | $-747,053,000 | $-1,039,769,000 |
| Net Business Purchase And Sale | $-86,773,000 | $-115,155,000 | $-88,391,000 | $104,842,000 |
| Sale Of Business | $0 | $125,662,000 | $0 | $125,985,000 |
| Purchase Of Business | $-86,773,000 | $-240,817,000 | $-88,391,000 | $-21,143,000 |
| Change In Working Capital | $105,745,000 | $44,775,000 | $82,945,000 | $118,860,000 |
| Change In Other Working Capital | $147,297,000 | $114,275,000 | $145,243,000 | - |
| Change In Payables And Accrued Expense | $-25,285,000 | $-28,640,000 | $-40,732,000 | $136,293,000 |
| Change In Payable | $-25,285,000 | $-28,640,000 | $-40,732,000 | $136,293,000 |
| Change In Account Payable | $-25,285,000 | $-28,640,000 | $-40,732,000 | $136,293,000 |
| Change In Receivables | $-16,267,000 | $-40,860,000 | $-21,566,000 | $-17,433,000 |
| Changes In Account Receivables | $-16,267,000 | $-40,860,000 | $-21,566,000 | $-17,433,000 |
| Other Non Cash Items | $-115,906,000 | $-78,354,000 | $-83,853,000 | $-127,392,000 |
| Stock Based Compensation | $14,410,000 | $31,766,000 | $14,480,000 | $26,456,000 |
| Asset Impairment Charge | $-893,000 | $22,978,000 | $-5,601,000 | $7,004,000 |
| Deferred Tax | $3,845,000 | $-1,693,000 | $-14,605,000 | $-6,001,000 |
| Deferred Income Tax | $3,845,000 | $-1,693,000 | $-14,605,000 | $-6,001,000 |
| Depreciation Amortization Depletion | $1,022,118,000 | $1,026,450,000 | $724,110,000 | $710,569,000 |
| Depreciation And Amortization | $1,022,118,000 | $1,026,450,000 | $724,110,000 | $710,569,000 |
| Amortization Cash Flow | $-36,747,000 | $-30,755,000 | $-25,791,000 | - |
| Amortization Of Intangibles | $-36,747,000 | $-30,755,000 | $-25,791,000 | - |
| Depreciation | $1,058,865,000 | $1,057,205,000 | $749,901,000 | - |
| Earnings Losses From Equity Investments | $173,984,000 | $1,515,000 | $-10,204,000 | $-2,049,000 |
| Gain Loss On Investment Securities | $-69,488,000 | $-178,695,000 | $-86,463,000 | $-33,115,000 |
| Gain Loss On Sale Of Business | $0 | $-77,548,000 | $-234,000 | $-311,438,000 |
| Net Income From Continuing Operations | $101,027,000 | $267,303,000 | $334,757,000 | $516,424,000 |
| Net Short Term Debt Issuance | - | - | $-275,606,000 | $-170,369,000 |
| Short Term Debt Payments | - | - | $-10,620,311,000 | $-16,052,522,000 |
| Short Term Debt Issuance | - | - | $10,344,705,000 | $15,882,153,000 |
| Effect Of Exchange Rate Changes | - | - | - | $0 |
| Net Investment Purchase And Sale | - | - | - | $0 |
| Purchase Of Investment | - | - | - | $0 |
Fetched: 2026-06-17